A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants
Clinical trial NCT06258174 · COMPLETED
Trial details
- NCT number
- NCT06258174
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2021-12-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.